Lusong Luo

3.6k total citations
48 papers, 1.5k citations indexed

About

Lusong Luo is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lusong Luo has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Lusong Luo's work include Chronic Lymphocytic Leukemia Research (7 papers), Cancer-related Molecular Pathways (7 papers) and Hedgehog Signaling Pathway Studies (7 papers). Lusong Luo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Cancer-related Molecular Pathways (7 papers) and Hedgehog Signaling Pathway Studies (7 papers). Lusong Luo collaborates with scholars based in China, United States and Australia. Lusong Luo's co-authors include Robert A. Copeland, Peter J. Tummino, Poulikos I. Poulikakos, Zhan Yao, Anthony Tao, Neal Rosen, Qi Li, Yijun Gao, Omar Abdel‐Wahab and Neilawattie M. Torres and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Lusong Luo

48 papers receiving 1.5k citations

Peers

Lusong Luo
Giovanni Di Maira Italy
Sébastien Jeay Switzerland
Christine M. Chresta United Kingdom
Amro Aboukameel United States
Chang Hun Rhee South Korea
Doris R. Siwak United States
Alexandra Grassian United States
Inge Tinhofer Austria
Esther Landesman‐Bollag United States
Narsis Attar United States
Giovanni Di Maira Italy
Lusong Luo
Citations per year, relative to Lusong Luo Lusong Luo (= 1×) peers Giovanni Di Maira

Countries citing papers authored by Lusong Luo

Since Specialization
Citations

This map shows the geographic impact of Lusong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lusong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lusong Luo more than expected).

Fields of papers citing papers by Lusong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lusong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lusong Luo. The network helps show where Lusong Luo may publish in the future.

Co-authorship network of co-authors of Lusong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Lusong Luo. A scholar is included among the top collaborators of Lusong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lusong Luo. Lusong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Zhanhui, Xu Wang, Lin Yu, et al.. (2020). Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity. European Journal of Medicinal Chemistry. 205. 112537–112537. 17 indexed citations
3.
Zhu, Fang, Yujie Wang, Qian Du, et al.. (2019). Structural optimization of aminopyrimidine-based CXCR4 antagonists. European Journal of Medicinal Chemistry. 187. 111914–111914. 11 indexed citations
4.
Song, Shiwei, Jin-Yi Jiang, Li Zhao, et al.. (2019). Structural optimization on a virtual screening hit of smoothened receptor. European Journal of Medicinal Chemistry. 172. 1–15. 7 indexed citations
5.
Chen, Qin, Haoran Zhang, Meng Wu, et al.. (2018). Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis. Journal of Pharmacological Sciences. 137(3). 256–264. 14 indexed citations
6.
Ma, Haikuo, Qin Chen, Fang Zhu, et al.. (2018). Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor. European Journal of Medicinal Chemistry. 149. 110–121. 9 indexed citations
7.
Lu, Wenfeng, Dihua Zhang, Haikuo Ma, et al.. (2018). Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays. European Journal of Medicinal Chemistry. 155. 34–48. 24 indexed citations
8.
Li, Zhanhui, Yujie Wang, Chunyan Fu, et al.. (2018). Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists. European Journal of Medicinal Chemistry. 149. 30–44. 16 indexed citations
9.
Ariazi, Jennifer L., Kevin J. Duffy, Duke M. Fitch, et al.. (2017). Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia. Journal of Pharmacology and Experimental Therapeutics. 363(3). 336–347. 69 indexed citations
10.
Xu, Xiangxiang, Haikuo Ma, Jiyue Zheng, et al.. (2016). Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the ‘reversed’ amide scaffold. Bioorganic & Medicinal Chemistry. 24(22). 5861–5872. 17 indexed citations
11.
Yang, Zhaohui, Haikuo Ma, Zhijian Sun, et al.. (2015). Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3665–3670. 17 indexed citations
12.
Zhang, Lianhai, Yiqiang Liu, Xiaohong Wang, et al.. (2015). The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice. Scientific Reports. 5(1). 9447–9447. 35 indexed citations
13.
Yao, Zhan, Neilawattie M. Torres, Anthony Tao, et al.. (2015). BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition. Cancer Cell. 28(3). 370–383. 358 indexed citations
14.
Dong, Yan, Kehuang Li, Haikuo Ma, et al.. (2015). Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors. Bioorganic & Medicinal Chemistry. 23(21). 6855–6868. 17 indexed citations
15.
Ma, Haikuo, Wenfeng Lu, Zhijian Sun, et al.. (2014). Design, synthesis, and structure–activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists. European Journal of Medicinal Chemistry. 89. 721–732. 20 indexed citations
16.
Aller, Glenn S. Van, Christine Fernandes, Ruth Lehr, et al.. (2008). Characterization of PI3K class IA isoforms with regulatory subunit p55α using a scintillation proximity assay. Analytical Biochemistry. 383(2). 311–315. 9 indexed citations
17.
Lad, Latesh, Lusong Luo, Jeffrey D. Carson, et al.. (2008). Mechanism of Inhibition of Human KSP by Ispinesib. Biochemistry. 47(11). 3576–3585. 98 indexed citations
18.
Lakdawala, Ami S., Frank T. Coppo, Lusong Luo, et al.. (2007). Characterization of an exosite binding inhibitor of matrix metalloproteinase 13. Protein Science. 17(1). 66–71. 38 indexed citations
19.
Luo, Lusong, Cynthia A. Parrish, Neysa Nevins, et al.. (2007). ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism. Nature Chemical Biology. 3(11). 722–726. 92 indexed citations
20.
Luo, Lusong, Jeffrey D. Carson, Dashyant Dhanak, et al.. (2004). Mechanism of Inhibition of Human KSP by Monastrol:  Insights from Kinetic Analysis and the Effect of Ionic Strength on KSP Inhibition. Biochemistry. 43(48). 15258–15266. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Di Maira Breakdown of academic impact, for papers by Sébastien Jeay Breakdown of academic impact, for papers by Christine M. Chresta Breakdown of academic impact, for papers by Amro Aboukameel Breakdown of academic impact, for papers by Chang Hun Rhee Breakdown of academic impact, for papers by Doris R. Siwak Breakdown of academic impact, for papers by Alexandra Grassian Breakdown of academic impact, for papers by Inge Tinhofer Breakdown of academic impact, for papers by Esther Landesman‐Bollag Breakdown of academic impact, for papers by Narsis Attar
Rankless by CCL
2026